Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. divulges novel Nav1.7 channel blockers

Oct. 11, 2017

DUB inhibitors presented by Mission Therapeutics

Oct. 11, 2017

Bristol-Myers Squibb presents compounds for treating HCV infections

Oct. 11, 2017

Novel Ret inhibitors presented by Blueprint Medicines

Oct. 10, 2017

DGMIF and Gachon University patent FGFR inhibitors

Oct. 10, 2017

Centaurus BioPharma and collaborators divulge novel CDK inhibitors

Oct. 10, 2017

New integrin antagonists presented by GlaxoSmithKline

Oct. 10, 2017

Bayer presents Pim kinase inhibitors

Oct. 10, 2017

New endonucleases inhibitors presented by Biotech Innovations

Oct. 9, 2017

University of Michigan and Kura Oncology patent menin-MLL interaction inhibitors

Oct. 9, 2017

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...